Spyre Therapeutics, Inc. ($SYRE)
Filing Information
| Accession Number | 0001853327-26-000008 |
|---|---|
| Form Type | 4 |
| Filing Date | Jun 27, 2026 |
| Document | View SEC Filing |
Transactions
4
Total Shares
45,000
Total Value
$1,524,500.00
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Chief Financial Officer | Common Stock | โ | Jun 25, 2026 | Exercise/Conversion | 15,000 | $14.50 | $217,500.00 | 112,994 | Direct | โ | View Details | |
Chief Financial Officer | Common Stock | โ | Jun 25, 2026 | Sale | 5,000 | $87.12 | $435,600.00 | 107,994 | Direct | โ | View Details | |
Chief Financial Officer | Common Stock | โ | Jun 25, 2026 | Sale | 10,000 | $87.14 | $871,400.00 | 97,994 | Direct | โ | View Details | |
Chief Financial Officer | Stock Option (Right to Buy) | Derivative | Jun 25, 2026 | Exercise/Conversion | 15,000 | $0.00 | $0.00 | 359,857 | Direct | โ | View Details |